High dose simvastatin and adverse muscle effects

Article Sidebar

PDF
Published: Dec 23, 2011
DOI: https://doi.org/10.18051/UnivMed.2011.v30.135-137 Universa Medicina
Abstract Viewed: 257
PDF Downloaded: 110

Main Article Content

Yenny Yenny

Abstract

High blood cholesterol, or hyperlipidemia, is a cardiovascular risk factor. Surveys have demonstrated that 35.6% of adults in the United States suffer from hyperlipidemia.(1) Currently there are various therapeutic regimens available for hyperlipidemia. The use of lipid-lowering drugs, patient education, dietary modification, and exercise have all been recommended for the management of hyperlipidemia.

Article Details

How to Cite
Yenny, Y. (2011). High dose simvastatin and adverse muscle effects. Universa Medicina, 30(3), 135–137. https://doi.org/10.18051/UnivMed.2011.v30.135-137
Issue
Vol. 30 No. 3 (2011)
Section
Review Article

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

References

Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics, 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25–146.

Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf. Accessed August 1, 2011.

Smith MEB, Lee NJ, Haney E, Carson S. Drug class review: HMG-CoA reductase inhibitors (statins) and fixed-dose combination products containing a statin. Final report. Update 5. Portland: Oregon Health & Science University;2009. Available at: http://www.ncbi.nlm.nih.gov/books/NBK47273/pdf/TOC.pdf. Accessed August 1, 2011.